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Received September 10, 2012; accepted January 14, 2013AbstractBackground: The management of ovarian tumors during pregnancy can be challenging because of the risk of fetal wastage and the possibility of
surgery-related complications, or a delayed diagnosis of a possibly lethal disease or malignancy. The aim of this study was to study the
characteristics and outcomes of pregnant women undergoing surgical intervention for ovarian tumors during pregnancy.
Methods: We reviewed the data of 102 pregnant women who underwent ovarian surgery between 2000 and 2010 at Taipei Veterans General
Hospital, Taiwan. Data subject to analysis included gestational age at the time of surgery, complications, surgical and pathological findings, and
the outcome of pregnancy.
Results: Fifty-two women who underwent surgery were excluded, whether by cesarean section, during the postpartum period or during simul-
taneous abortion surgery. Ultimately, the data of 50 patients were analyzed. Almost all patients (n ¼ 46, 92%) were asymptomatic and underwent
elective surgery. Frequently, this surgery was done in the second trimester (n ¼ 35, 70%). We determined that teratoma (26%), mucinous cys-
tadenomas (20%), and endometriomas (16%) were the threemost common pathological findings. Nonspecific ovarian tumors were common (28%),
including seven corpus luteum cysts, six simple cysts, and one paratubal cyst. Twowomen were diagnosed with malignant ovarian tumors, but both
were metastatic and the primary site was the colon. Ten women underwent laparoscopic surgery. General anesthesia was used in four patients, and
all underwent emergency exploratory laparotomy. There was no surgery-related complication or instance of preterm labor.
Conclusion: In our study cohort, surgical intervention during pregnancy was safe, since neither surgical approach, such as exploratory lapa-
rotomy or laparoscopic surgery, nor anesthesia methods, for example general anesthesia or spinal anesthesia showed negative impact on the
pregnancy outcomes. Reported cases of malignant ovarian tumor are still rare, thus, the possibility of metastatic tumor should be considered first.
Copyright  2013 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Although ovarian cyst or tumor during pregnancy is rela-
tively common, the majority of them spontaneously disappear
during customary medical follow-up.1 Only a few tumors
typically persist and require further surgical intervention.
However, the management of ovarian tumors during preg-
nancy can be challenging, not only for the obstetricians buthinese Medical Association. All rights reserved.
Fig. 1. Distribution of women undergoing ovarian surgery based on different
trimesters.
453F.-H. Koo et al. / Journal of the Chinese Medical Association 76 (2013) 452e457also for the pregnant women. The main concerns affecting
patient medical management include the risk of fetal wastage,2
the possibility of surgery-related complications, or a delayed
diagnosis of a possible lethal disease or malignancy.3 There-
fore, it is sometimes problematic to make the decision to
intervene surgically, even though it is related to the nature of
the emergency, such as torsion or rupture, tumor size, potential
risks of complications, possibility of malignancy,5 gestational
age at the time of diagnosis, and maternal age.6 To minimize
the above-mentioned risks, the assistance of a well-trained
team in a tertiary hospital, including obstetricians, gynecolo-
gists, pediatricians, anesthetic experts, and other specialists, is
always advantageous.
In this study, we retrospectively reviewed 50 patients who
underwent surgical intervention during pregnancy over a
period of 11 years, to assess the surgical effects and charac-
teristics of ovarian tumors during pregnancy.
2. Methods
Between 2000 and 2010, there were 17,586 deliveries at
Taipei Veterans General Hospital e a medical-school-
associated medical center in Northern Taiwan. Of these de-
liveries, 102 involved ovarian surgery during pregnancy and
the intrapartum period. Most patients were symptom-free and
a few had nonspecific and mild symptoms, for example,
abdominal fullness. For those patients with asymptomatic
ovarian tumors during pregnancy, the indications for preven-
tive surgery were individualized, based on the following
considerations: tumor size, growth pattern, morphology in
imaging studies, tumor location, and the patients’ or doctors’
attitudes. Patients with a significant symptom, such as torsion
or rupture, were treated with emergency surgery.
Preoperative patient evaluation included ultrasound exam-
ination, serum biochemistry, tumor markers, complete blood
count, and electrocardiography, as well as consultations with
anesthesiologists and neonatologists. Routine cardiotocog-
raphy (CTG) e continuous electronic fetal heart rate moni-
toring e was performed before and 48 hours after the
operation. Progesterone, b2 agonist, or magnesium sulfate
tocolytic agents were used with all patients who underwent
surgery during pregnancy, regardless of their gestational age.8
Tocolytic treatment was started on the day before surgery and
continued for 24e48 hours postoperatively to prevent preterm
labor. Data collected included age, gravidity, parity, gesta-
tional age (at diagnosis, disposition, and delivery), complica-
tions related to pregnancy, operative and pathological findings,
methods of anesthesia, and pregnancy outcome. Approval for
the study was obtained from the local ethics committee
(VGHIRB 98-11-02).
3. Results
Thirty-four women who underwent surgery during cesarean
section or the postpartum period and 18 who underwent
simultaneous abortion surgery in the early trimester were
excluded from the analysis. The remaining 50 patients wereincluded. The age distribution of this study cohort did not
differ from that of the other women giving birth within the
same period in the same hospital (data not shown). The ma-
jority of patients (37/50, 74%) were treated in the second
trimester, and 12 underwent ovarian surgery in the first
trimester (Fig. 1). The pathological diagnoses of these
remaining patients included mature cystic teratoma (13/50,
26%), mucinous cystadenoma (10/50, 20%), endometriosis or
chocolate cyst (8/50, 16%), corpus luteum (n ¼ 7), simple cyst
(n ¼ 6), serous cystadenoma (n ¼ 2), metastatic ovarian car-
cinoma from the colon (n ¼ 2), and paratubal cyst (n ¼ 1)
(Table 1).
Five women (10%) had a tumor size < 5 cm, 36 (72%)
between 5 cm and 10 cm, five (10%) between 10 cm and
15 cm, and four (8%) > 15 cm. The relationship between
tumor size and pathological diagnosis is also described in
Table 1.
Forty-six women were treated by elective surgery during
pregnancy and four underwent emergency exploratory lapa-
rotomy under general anesthesia for acute abdomen after
failure of conservative treatment. All surgical findings were
torsion and pathological findings were teratoma (2/4, 50%)
and corpus luteal cyst (2/4, 50%). The size of these four tu-
mors with torsion ranged from 5 cm to 10 cm (median,
7.8 cm).
Table 2 shows the characteristics of the women undergoing
ovarian surgery during pregnancy. Cystectomy was performed
in 27 patients (54%), and oophorectomy in 23 (46%) (Table 3).
Only five patients (10%) were given regional (spinal) anes-
thesia, and all underwent elective exploratory laparotomy.
4. Discussion
The treatment of ovarian tumors in pregnancy is still
challenging, because the treatment decision is often associated
with unacceptable errors, for example, the sometimes unjus-
tified termination of pregnancies, or the choice of an inade-
quate strategy for treatment of a tumor because of fear of
compromised fetal health or cancer risk.9,10 In addition, most
pregnant women visit obstetricians from the early weeks of
gestation, and ultrasonographic evaluation is now widely used;
both of which result in not only an increased detection rate of
Table 1
Relationship between tumor size and histological diagnosis in pregnant
women undergoing ovarian surgery.
Tumour size (cm)
<5 5e10 10e15 15e20 Total
Mature cystic teratoma 1 10 2 0 13
Mucinous cystadenoma 0 1 6 3 10
Endometriosis 1 5 2 0 8
Corpus luteal cyst 4 3 0 0 7
Simple cyst 0 3 1 2 6
Serous cystadenoma 0 1 1 0 2
Paratubal cyst 0 1 0 0 1
Cystadenofibroma 0 1 0 0 1
Metastatic carcinoma 0 1 1 0 2
Total 6 26 13 5 50
Table 3
Comparison of exploratory laparotomy and laparoscopic surgery during
pregnancy.
Characteristics Exploratory
(n ¼ 40)
Laparoscopy
(n ¼ 10)
Total (%)
Cystectomy 23 4 27 (54)
Oophorectomy 17 6 23 (46)
General anesthesia 35 10 45 (90)
Regional anesthesia 5 0 5 (10)
Elective 36 10 46 (92)
Urgent 4 0 4 (8)
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detection of asymptomatic and clinically unapparent lesions.12
Furthermore, this detection rate is the highest during the first
trimester, as shown by Ueda and Ueki, who detected 90.3% of
tumor-like lesions and 78.8% of benign tumors before the 10th
gestational week.13 Whitecar and colleagues have reported
that the majority of the above-mentioned masses in the first
trimester are corpus luteum or other functional cysts that
usually resolve by the 16th gestational week.14
Thus, it is widely recommended that these masses should
be managed conservatively, because the majority of ovarian
tumors in pregnant women spontaneously disappear during
follow-up1; that is to say, that only a few tumors are persistent
and need further surgical intervention. In 2005, Schmeler and
colleagues tried to estimate whether delaying surgery affects
the risk of adverse maternal and fetal outcomes in patients
diagnosed with an adnexal mass during pregnancy.15 They
have concluded that close observation is a reasonable alter-
native to antepartum surgery in patients with an adnexal mass
during pregnancy in selected cases.15 In addition, Katz et al’s
study of a high-risk group (teratoma during pregnancy) failed
to identify an unfavorable prognosis with these tumors,
because complications are extremely rare.16 Therefore, these
tumors should be managed conservatively, if possible, with
routine ultrasonography follow-up during pregnancy.16Table 2
Characteristics of ovarian surgery during pregnancy.
Characteristics Mean  standard deviation
Age (y) 30.0  4.3
Body mass index (kg/m2) 22.1  2.6
Blood loss during surgery (mL) 159.7  176.9
Gestational age at surgery 15 wk and 1.3 d  8 wk and 1.0 d
Surgical time (min) 95.2  56.6
Hospitalization stay (d) 8.4  5.3
Gestational age of delivery 38 wk and 3.3 d  1 wk and 3.7 d
Birth weight of fetuses (g) 3113.0  300.5
Sex of fetus Male: 30
Female: 20
Apgar score at 1 min 7.7  0.9
Apgar score at 5 min 8.9  0.4
Delivery methods Vaginal delivery: 40
Cesarean section: 10However, it is also important to confirm resolution of the
mass or to excise it to make a pathological diagnosis. This
results in a great deal of controversy because it is hard to make
a decision to select good candidates at appropriate times to
undergo ovarian surgery in pregnant women.
Nearly all studies have found that cystic teratoma is the
most common tumor removed during pregnancy (up to
40e50%), but there is no doubt that the corpus luteum of the
pregnancy and simple cysts are still frequently seen in the
pathological diagnosis of ovarian tumor during pregnancy,
ranging from 11% to 41%.15e17 After careful evaluation of
these reports, it was found that not all of the tumors were
asymptomatic. For example, in our previous study, the final
pathological diagnoses of the pregnant women undergoing
emergency laparotomy at the first trimester showed that 50%
(8/16) had functional cysts.17 In addition, up to 42.9% (3/7) of
these women were complicated with spontaneous abortion.17
An acute abdomen, in particular, might be one of the most
urgent situations, and may be accompanied with early fetal
loss if ovarian torsion occurs during the first trimester.1 In fact,
the most frequently seen and serious complication of ovarian
tumor during pregnancy is torsion; rupture of the tumor is
rare.18 It has been reported that the torsion rate of adnexal
masses during pregnancy is 10e15%; however, the majority of
cases (ovarian torsion during pregnancy) are seen gestational
weeks 8e16, at which point the uterus grows faster.18 Chang
and colleagues have researched the topic of ovarian torsion
during pregnancy, and found that the majority of cases (75%)
occurred in the first trimester and 30% were mature tera-
tomas.19 In 2009, the same group studied 174 patients and
showed that only 5.9% of ovarian torsions occurred after 20
weeks, suggesting a higher risk of ovarian torsion before 20
weeks gestational age20; this was also demonstrated in another
study.11 In addition, the highest risk of ovarian torsion exists
between the 10th and 17th week of gestation (60%).19 Finally,
ovarian torsion does not always occur with pathological
findings; that is to say, the percentage of functional cysts
(corpus luteum cyst and follicular cyst) is high: for example,
35% in the study of Chang and colleagues19 and 41% in
another study.11
Another issue worthy of our attention is the possibility of
malignant ovarian tumors, because these tumors hold 2e6% of
adnexal masses detected during pregnancy.21 Many scoring
systems used to distinguish the differences between malignant
ovarian tumors and other benign situations have been
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characteristics, such as the size of an adnexal mass (total
volume > 50 mL), echogenicity (presence of a solid compo-
nent), internal borders (wall thickness or irregularity), presence
of septations (thick) and papillary projections (defined as solid
projections into a cyst cavity from a cyst wall of >3 mm in
height), and resistance Doppler waveform with a pulsatility
index < 1.0 or a resistance index < 0.4e0.8.23,24,26 However,
this issue is not further discussed here; we have discussed only
tumor size, which is a subject of controversy when we consider
whether these tumors should be removed during pregnancy.
Two studies have supported a cutoff value of 10 cm, because
tumor diameters  10 cm at the initial diagnosis during preg-
nancy had a higher risk of malignancy.21 However, if we
consider the possibility of ovarian torsion, the cutoff value of
tumor size might range from 6 cm to 8 cm, because tumors of
this size have a significantly higher risk of torsion.19
Finally, we found no pregnant women who were compli-
cated with spontaneous abortion if the ovarian surgery was
performed on an elective basis, even though the final pathol-
ogy was corpus luteum, based on our previous studies17 and
the current study. Therefore, we favor the use of prophylactic
surgery (preferably the laparoscopic approach) to remove
mature teratomas at week 8 of gestation, to minimize the risk
of fetal loss during pregnancy without contraindication,
because we found no fetal loss after week 8 of gestation in
elective surgery.5 In addition, teratoma components of ovarian
masses that were <5 cm did not seem to escape the risk of
torsion.17 An urgent operation might increase the risk of fetal
loss before the 10th week of gestation, especially in cases of
mature teratoma.17 Of greater importance, however, is that the
diagnosis of mature teratoma is easy through high-resolution
ultrasound in early pregnancy; this type of tumor teratoma is
prone to torsion during the first trimester.1
Therefore, questions regarding how or when to treat those
pregnant women with asymptomatic, nonsuspicious cystic
ovarian masses, and who should be treated with surgical
intervention for adnexal masses during pregnancy remain
unanswered. Providing answers to these questions is no simple
matter, and there is substantial controversy if issues such as
anesthesia risk, fetal loss, fear of malignancy, and anxiety
regarding overmanipulation of the functional ovarian cysts
(which often spontaneously disappear) are taken into consid-
eration.5 No one answer can totally satisfy all clinicians, or
persuade those pregnant women involved. Some suggestions
from our study include the need to maintain regular patient
follow-up with high-resolution ultrasonography, and attention
to clinical symptoms and other signs for those pregnant
women with an accidental finding of ovarian tumor; any
medical management strategy should not have a negative
impact on the wellbeing of either the mother or the fetus. If
possible, the treatment of every pregnant woman, and by
extension every woman of childbearing age, should include a
wider reflection on how to preserve the pregnancy or subse-
quent fertility, or both.28
We excluded 18 women from the analysis because they
underwent ovarian surgery, simultaneous with either medicalor surgical abortion therapy.29 Although some of the women
had unexpected pregnancies, doubtless some of them were
afraid of the teratogenic effects and unpredictable risk to the
fetus associated with general anesthesia and ovarian surgery,
ultimately resulting in the decision to abort. Twelve women in
this study underwent ovarian surgery in the first trimester, and
four (33.3%) requested amniocentesis, in part due to the
above-mentioned reasons.30 It is worth noting that none of
them were indicated for amniocentesis secondary to advanced
maternal age, which is a major reason why pregnant women
ask for amniocentesis.32,33
All newborns in this study (n ¼ 50) were born essentially
normal, suggesting that neither anesthesia nor gestational age
at the time of ovarian surgery affected the fetuses, although the
development of the fetuses after birth was not really evaluated
in this study. However, based on a review of the liter-
ature,34e38 there are no known teratogenic effects from the use
of commonly administered anesthetic agents at standard con-
centrations at any gestational age.39 A review of nonobstetric
surgery from the Swedish Health Registry involving pregnant
women between 4 and 20 gestational weeks, including 2181
laparoscopies and 1522 laparotomies, found that neither
congenital malformations (5.0% in the laparoscopy group and
4.1% in the laparotomy group) nor still births and neonatal
deaths (1.3% and 1.7%, respectively) were significantly
increased compared to the normal population,37 suggesting
anesthesia between 4 and 20 gestational weeks was safe.
Besides the teratogenic effects of anesthesia, other fetal
complications of ovarian surgery during pregnancy may
include those related to the development of changes in fetal
hemodynamics, leading to the common practice of fetal
monitoring during surgery. Documentation of fetal wellbeing
before and after the surgical procedure, including ovarian
surgery, can be accomplished through a reassuring electronic
fetal heart rate monitoring or biophysical profile.40,41 By
contrast, the need for intraoperative fetal heart rate monitoring
is more controversial, because little is known about normal
fetal physiological responses to maternal anesthesia and sur-
gical stress.39 It is relatively difficult to establish a confident
threshold point where it would be obviously necessary to
intervene in the setting of a fetal heart rate monitoring
mechanism.39 Furthermore, it is difficult to set up CTG when
the pregnant women (as patients) are undergoing abdominal
surgery. A large systemic review of 224 articles also found that
there were no fetal heart rate abnormalities in pregnant women
during nonobstetric surgery.38 However, the concerns of
pregnant women and obstetricians regarding fetal wellbeing
are always present. The American College of Obstetricians
and Gynecologists states that fetal heart rate monitoring dur-
ing nonobstetric surgery in pregnant women should be eval-
uated on an individual basis, and according to the physician’s
judgment.42
In our study, the fetal status was not monitored during
ovarian surgery, although CTG was used routinely before and
after operation. The use of CTG after operation was based on
the observation of an increased risk of low-birthweight infants
(< 1.5 kg) due to prematurity and intrauterine growth
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women who were treated with nonobstetric surgery during
pregnancy.34 The routine use of CTG after a surgical proce-
dure in pregnant women might help to predict the occurrence
of preterm labor. With CTG results as a basis, the use of
tocolytic agents can be immediate and prompt, because their
use in pregnant women undergoing nonobstetric surgery is
also controversial. There are no data to date demonstrating a
benefit of the use of tocolytic agents for pregnant women with
nonobstetric surgery during pregnancy.39 A systemic review
also failed to support the benefits of the routine use of pro-
phylactic tocolytics for pregnant women who need non-
obstetric surgery during pregnancy.36 By contrast, the use of
tocolytics should be reserved for circumstances in which ev-
idence of preterm labor is apparent.36 However, in an effort to
minimize the risk of low-birthweight infants and early
neonatal death,34 we continue to favor the use of prophylactic
tocolytic agents in the perioperative setting. In this study, we
administered tocolytic agents routinely, whether progesterone,
b2 agonist, or magnesium sulfate, for all women who under-
went ovarian surgery, regardless of gestational age, and the
outcomes appeared to be positive. None of the pregnant
women suffered preterm labor or complications attributable to
tocolytic treatment.
The efficacious selection of tocolytic agents would typi-
cally depend on the experience of the clinicians, and the
clinical conditions of the pregnant women. These tocolytic
agents can be administered either before or immediately after
surgery, and continued postoperatively for 24 hours or 48
hours therapy. No prospective or randomized studies have
demonstrated the superiority of one type of tocolytic agent
over the others.8
There are many important issues regarding the character-
istics of the ovarian tumor during pregnancy. First, the fre-
quency of occurrence of teratoma is common, and contributes
to the high risk of a surgical emergency during pregnancy,
secondary to torsion. This suggests the need for a routine
adnexal evaluation prior to conception, and surgical inter-
vention before conception should be considered. Second,
functional cysts, including follicular cysts, simple cysts, or
paraovarian or paratubal cysts are also common, and are not
always free of risk; there were two cases of cysts complicated
with acute abdomen during pregnancy in our study. Third, the
risk of malignancy is low during pregnancy, as demonstrated
by the fact that only two women in our study had malignant
ovarian tumors. However, as also seen in this study, the
presence of a history of malignancy, especially gastrointestinal
tract malignancy, should prompt medical consultation prior to
conception. In addition, careful evaluation before conception
and during pregnancy should be emphasized, and any new
ovarian growth should be actively managed. Fourth, tumor
size is important. When the tumor is > 10 cm, surgical
intervention can be considered. However, surgery can be
delayed for those tumors < 5 cm. Nonetheless, if the tumor is
between 5 cm and 10 cm, it is difficult to make a recom-
mendation, although the risk of torsion is especially high in
tumors of this size. In terms of surgical methods for ovariantumor during pregnancy, either laparotomy or laparoscopy is
safe for the mother and fetus. In addition, there is no differ-
ence in outcome for women treated with general or regional
anesthesia.
In conclusion, our results demonstrate that ovarian surgery
is relatively safe for both mother and fetus, and can be
completed through either laparotomy or laparoscopy with
general or regional anesthesia. Early surgical intervention for
ovarian teratoma in pregnancy is still recommended when
ultrasound detects this type of tumor, regardless of gestational
age. For pregnant women with a history of malignancy, any
adnexal mass lesion should be actively managed.Acknowledgments
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